60 related articles for article (PubMed ID: 35576541)
21. Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old.
Medeiros GX; Sasahara GL; Magawa JY; Nunes JPS; Bruno FR; Kuramoto AC; Almeida RR; Ferreira MA; Scagion GP; Candido ÉD; Leal FB; Oliveira DBL; Durigon EL; Silva RCV; Rosa DS; Boscardin SB; Coelho V; Kalil J; Santos KS; Cunha-Neto E
Front Immunol; 2022; 13():812126. PubMed ID: 35300337
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
23. Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers.
Angkasekwinai N; Sewatanon J; Niyomnaitham S; Phumiamorn S; Sukapirom K; Sapsutthipas S; Sirijatuphat R; Wittawatmongkol O; Senawong S; Mahasirimongkol S; Trisiriwanich S; Chokephaibulkit K
Vaccine X; 2022 Apr; 10():100153. PubMed ID: 35282410
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
[TBL] [Abstract][Full Text] [Related]
25. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
26. A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
Joudi M; Moradi Binabaj M; Porouhan P; PeyroShabany B; Tabasi M; Fazilat-Panah D; Khajeh M; Mehrabian A; Dehghani M; Welsh JS; Keykhosravi B; Akbari Yazdi A; Ariamanesh M; Ghasemi A; Ferns G; Javadinia SA
Front Endocrinol (Lausanne); 2022; 13():798975. PubMed ID: 35299966
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.
Keskin AU; Bolukcu S; Ciragil P; Topkaya AE
J Med Virol; 2022 Jan; 94(1):39-41. PubMed ID: 34536028
[No Abstract] [Full Text] [Related]
29. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.
Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L
Front Immunol; 2022; 13():829665. PubMed ID: 35154152
[TBL] [Abstract][Full Text] [Related]
30. Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients.
Gualano B; Saad CGS; Sieczkowska SM; Lemes ÍR; da Silva RP; Pinto AJ; Mazzolani BC; Smaira FI; Gil S; Oliveira-Junior G; Aikawa NE; Medeiros-Ribeiro AC; Silva CA; Yuki EFN; Pasoto SG; Pereira RMR; Shinjo SK; Andrade DCO; Sampaio-Barros PD; Roschel H; Bonfa E
J Appl Physiol (1985); 2022 Mar; 132(3):682-688. PubMed ID: 35142560
[TBL] [Abstract][Full Text] [Related]
31. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
32. Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients.
Cheung KS; Lam LK; Hui RWH; Mao X; Zhang RR; Chan KH; Hung IF; Seto WK; Yuen MF
Clin Mol Hepatol; 2022 Jul; 28(3):553-564. PubMed ID: 35545127
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.
Yalçın TY; Topçu DI; Doğan Ö; Aydın S; Sarı N; Erol Ç; Kuloğlu ZE; Azap ÖK; Can F; Arslan H
J Med Virol; 2022 Jan; 94(1):279-286. PubMed ID: 34468990
[TBL] [Abstract][Full Text] [Related]
34. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
Front Immunol; 2021; 12():744887. PubMed ID: 34712232
[TBL] [Abstract][Full Text] [Related]
35. Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy.
Soysal A; Bilazer C; Gönüllü E; Barın E; Çivilibal M
Hum Vaccin Immunother; 2021 Oct; 17(10):3484-3486. PubMed ID: 34325615
[TBL] [Abstract][Full Text] [Related]
36. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
[TBL] [Abstract][Full Text] [Related]
37. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
[TBL] [Abstract][Full Text] [Related]
38. The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac.
Ng HY; Liao Y; Zhang R; Chan KH; To WP; Hui CH; Seto WK; Leung WK; Hung IFN; Lam TTY; Cheung KS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473829
[TBL] [Abstract][Full Text] [Related]
39. The level of Ig anti-RBD SARS-CoV-2 after two doses of CoronaVac vaccine.
Ulhaq ZS; Soraya GV; Indriana K; Devitasari R; Pradiptha IPY; Zulfikar DB; Uxiana V; Zulkarnain ; Rachma LN; Arisanti D
J Med Virol; 2022 Mar; 94(3):829-832. PubMed ID: 34647630
[No Abstract] [Full Text] [Related]
40. Acute Coronary Syndrome After Inactivated SARS-COV-2 Vaccine.
Panthong S; Vimonsuntirungsri T; Thapanasuta M; Wanlapakorn C; Udayachalerm W; Ariyachaipanich A
Int Heart J; 2022; 63(2):388-392. PubMed ID: 35354757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
